Serum Cytokine Changes in a Patient with Chronic Pulmonary Aspergillosis Overlapping with Allergic Bronchopulmonary Aspergillosis: A Case Report

Yusei Tsukamoto,Yuya Ito,Yasushi Obase,Takahiro Takazono,Nana Nakada,Nobuyuki Ashizawa,Tatsuro Hirayama,Kazuaki Takeda,Shotaro Ide,Naoki Iwanaga,Masato Tashiro,Naoki Hosogaya,Susumu Fukahori,Chizu Fukushima,Katsunori Yanagihara,Koichi Izumikawa,Hiroshi Mukae
DOI: https://doi.org/10.2169/internalmedicine.2234-23
2024-01-01
Internal Medicine
Abstract:Allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) are diseases caused by Aspergillus infection, and CPA can develop from ABPA in some cases. We herein report a patient with CPA overlapping with ABPA. Serum cytokine levels were evaluated at 4 time points: the ABPA diagnosis, CPA diagnosis, 6 months after the start of voriconazole (VRCZ), and 12 months after re-administration of VRCZ. Interleukin (IL)-13 levels decreased upon glucocorticoid treatment, whereas IL-25 and IL-33 levels decreased rapidly with the initiation of antifungals. Early antifungal therapy may be important to control disease progression and prevent CPA overlap.
medicine, general & internal
What problem does this paper attempt to address?